Stock Information
Recursion Pharmaceuticals Inc (RXRX)
Ticker Symbol: RXRX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,719.32 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -1.2041
Revenue (TTM): $0.13 M
Dividend Yield: N/A%
ROE: -54.32%
Latest News
-
Morgan Stanley Maintains Equal-Weight on Recursion Pharmaceuticals, Raises Price Target to $5.5
Thu, May 14, 2026 1:23 PM
-
Recursion Pharmaceuticals, Inc. 2026 Q1 - Results - Earnings Call Presentation
Wed, May 13, 2026 7:14 PM
-
Recursion Pharmaceuticals, Inc. (RXRX) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Tue, May 12, 2026 5:30 PM
-
Transcript : Recursion Pharmaceuticals, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 10
Tue, May 12, 2026 2:05 PM
Key Financials
Financial data not available
